Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,892 | -5,287 | -12,094 | -7,864 | -978 |
| Depreciation Amortization | 3 | 1 | 1 | N/A | 6 |
| Accounts receivable | N/A | N/A | N/A | N/A | 120 |
| Accounts payable and accrued liabilities | 2,157 | 740 | 281 | -34 | -20 |
| Other Working Capital | 1,961 | 579 | -51 | -373 | 119 |
| Other Operating Activity | 2,157 | 1,375 | 6,781 | -93 | -149 |
| Operating Cash Flow | $-5,614 | $-2,592 | $-5,082 | $-8,363 | $-902 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 43 |
| PPE Investments | -23 | -5 | -10 | -7 | N/A |
| Net Acquisitions | 538 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $515 | $-5 | $-10 | $-7 | $43 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,871 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | 98 | N/A |
| Common Stock Issued | N/A | N/A | 1,346 | 5,845 | 3,166 |
| Other Financing Activity | 5,356 | 2,155 | 4,338 | 2,745 | 0 |
| Financing Cash Flow | $20,227 | $2,155 | $5,684 | $8,688 | $3,166 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -24 |
| Beginning Cash Position | 594 | 594 | 2 | 2 | 1,126 |
| End Cash Position | 15,722 | 152 | 594 | 320 | 3,409 |
| Net Cash Flow | $15,128 | $-442 | $592 | $319 | $2,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,614 | -2,592 | -5,082 | -8,363 | -902 |
| Capital Expenditure | -23 | -5 | -10 | -7 | N/A |
| Free Cash Flow | -5,637 | -2,597 | -5,092 | -8,370 | -902 |